Lowenthal Richard E 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-18 2:09 pm Purchase |
2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY |
Lowenthal Richard E | 7,422,432 7.900% |
7,422,432 (New Position) |
Filing |